AP1S2
AP-1 complex subunit sigma-2
Also known as: AP1S2_HUMAN, MRX59, MRXS5, PGS, SIGMA1B
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P56377
- Gene
- AP1S2
- Ensembl
- ENSG00000182287
- Chromosome
- X
- Canonical length
- 157 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Golgi apparatus,Vesicles
OverviewNCBI Gene
Adaptor protein complex 1 is found at the cytoplasmic face of coated vesicles located at the Golgi complex, where it mediates both the recruitment of clathrin to the membrane and the recognition of sorting signals within the cytosolic tails of transmembrane receptors. This complex is a heterotetramer composed of two large, one medium, and one small adaptin subunit. The protein encoded by this gene serves as the small subunit of this complex and is a member of the adaptin protein family. Transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2013]
Canonical amino-acid sequenceUniProt
157 residues, UniProt reviewed canonical sequence.
>P56377|AP1S2
1 MQFMLLFSRQ GKLRLQKWYV PLSDKEKKKI TRELVQTVLA RKPKMCSFLE WRDLKIVYKR
61 YASLYFCCAI EDQDNELITL EIIHRYVELL DKYFGSVCEL DIIFNFEKAY FILDEFLLGG
121 EVQETSKKNV LKAIEQADLL QEEAETPRSV LEEIGLTLocalizationUniProt · AlphaFold · HPA
Whether an antibody against AP1S2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.32
- Highest tissue expression
- 622 nTPM
Expression across tissuesHPA
Tissue
- epididymis: 622 nTPM
- tongue: 87 nTPM
- smooth muscle: 70 nTPM
- heart muscle: 69 nTPM
- skeletal muscle: 65 nTPM
- endometrium: 48 nTPM
Single-cell type
- epididymal principal cells: 1,801 nCPM
- monocytes: 401 nCPM
- cdc: 397 nCPM
- kupffer cells: 393 nCPM
- hofbauer cells: 378 nCPM
- platelets: 372 nCPM
Immune cell
- classical monocyte: 326 nTPM
- intermediate monocyte: 324 nTPM
- total PBMC: 227 nTPM
- myeloid DC: 221 nTPM
- non-classical monocyte: 176 nTPM
- plasmacytoid DC: 82 nTPM
Brain region
- hypothalamus: 80 nTPM
- pons: 78 nTPM
- medulla oblongata: 61 nTPM
- spinal cord: 52 nTPM
- white matter: 50 nTPM
- midbrain: 47 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about AP1S2.
Disease | AllUniProt
Conditions AP1S2 is implicated in, by any mechanism.
- Pettigrew syndrome (PGS) MIM:304340
Disease | GeneticClinVar
25 pathogenic / likely-pathogenic of 110 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Pettigrew syndrome
- Fried syndrome
- Thyroid cancer, nonmedullary, 1
- Inborn genetic diseases
- X-linked syndromic intellectual disability
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.45
- gnomAD pLI
- 0.87
- gnomAD missense Z
- 2.01
- DepMap mean gene effect
- -0.16
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- intracellular protein transport
- melanosome assembly
- platelet dense granule organization
- vesicle-mediated transport
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of AP1S2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads AP1S2 as an antibody target. Whether an autoantibody or antibody against AP1S2 could matter depends on whether native AP1S2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
AP1S2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label AP1S2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...